Literature DB >> 11297415

Antitumor action of seminal ribonuclease, its dimeric structure, and its resistance to the cytosolic ribonuclease inhibitor.

A Antignani1, M Naddeo, M V Cubellis, A Russo, G D'Alessio.   

Abstract

Bovine seminal RNase (BS-RNase) is a homodimeric enzyme with a cytotoxic activity selective for tumor cells. In this study, the relationships of its cytotoxic activity to its dimeric structure and its resistance to the cytosolic RNase inhibitor (cRI) are investigated systematically by site-directed mutagenesis. The results show that (1) the dimericity of BS-RNase is essential for its full cytotoxic action; (2) the role of the dimeric structure in the antitumor activity is that of making the enzyme insensitive to the cytosolic RNase inhibitor; (3) a RNase may not be completely insensitive to cRI to exploit a full cytotoxic potential.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11297415     DOI: 10.1021/bi002781m

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Second generation antitumour human RNase: significance of its structural and functional features for the mechanism of antitumour action.

Authors:  S Di Gaetano; G D'alessio; R Piccoli
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

2.  Binding assay and preliminary X-ray crystallographic analysis of ACTIBIND, a protein with anticarcinogenic and antiangiogenic activities.

Authors:  Marina de Leeuw; Levava Roiz; Patricia Smirnoff; Betty Schwartz; Oded Shoseyov; Orna Almog
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-07-28

3.  Comparative functional analysis of ribonuclease 1 homologs: molecular insights into evolving vertebrate physiology.

Authors:  Jo E Lomax; Chelcie H Eller; Ronald T Raines
Journal:  Biochem J       Date:  2017-06-21       Impact factor: 3.857

4.  Polyarginine as a multifunctional fusion tag.

Authors:  Stephen M Fuchs; Ronald T Raines
Journal:  Protein Sci       Date:  2005-06       Impact factor: 6.725

Review 5.  The RNase a superfamily: generation of diversity and innate host defense.

Authors:  Kimberly D Dyer; Helene F Rosenberg
Journal:  Mol Divers       Date:  2006-11       Impact factor: 2.943

Review 6.  Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity.

Authors:  Thomas J Rutkoski; Ronald T Raines
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

7.  Bovine brain ribonuclease is the functional homolog of human ribonuclease 1.

Authors:  Chelcie H Eller; Jo E Lomax; Ronald T Raines
Journal:  J Biol Chem       Date:  2014-07-30       Impact factor: 5.157

8.  Human recombinant RNASET2: A potential anti-cancer drug.

Authors:  Levava Roiz; Patricia Smirnoff; Iris Lewin; Oded Shoseyov; Betty Schwartz
Journal:  Oncoscience       Date:  2016-03-04

Review 9.  Biological Activities of Secretory RNases: Focus on Their Oligomerization to Design Antitumor Drugs.

Authors:  Giovanni Gotte; Marta Menegazzi
Journal:  Front Immunol       Date:  2019-11-26       Impact factor: 7.561

10.  Highly selective toxic and proapoptotic effects of two dimeric ribonucleases on thyroid cancer cells compared to the effects of doxorubicin.

Authors:  D Spalletti-Cernia; R Sorrentino; S Di Gaetano; R Piccoli; M Santoro; G D'Alessio; P Laccetti; G Vecchio
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.